PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-11.07%
Both yoy net incomes decline, with MCHP at -98.02%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-0.90%
Both reduce yoy D&A, with MCHP at -4.19%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
96.36%
Well above MCHP's 1.59% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
4.55%
SBC growth while MCHP is negative at -0.03%. John Neff would see competitor possibly controlling share issuance more tightly.
-149.76%
Both reduce yoy usage, with MCHP at -201.98%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-73.31%
Both yoy AR lines negative, with MCHP at -260.86%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-144.83%
Both reduce yoy inventory, with MCHP at -1558.96%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
54.88%
AP growth well above MCHP's 46.30%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-323.08%
Negative yoy usage while MCHP is 16.84%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
100.00%
Lower 'other non-cash' growth vs. MCHP's 1001.84%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-53.76%
Both yoy CFO lines are negative, with MCHP at -45.39%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
32.68%
Some CapEx rise while MCHP is negative at -11.83%. John Neff would see competitor possibly building capacity while we hold back expansions.
-1660.00%
Both yoy lines negative, with MCHP at -100.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
79.61%
Some yoy expansion while MCHP is negative at -99.32%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
60.84%
Proceeds from sales/maturities above 1.5x MCHP's 22.28%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
No Data
No Data available this quarter, please select a different quarter.
127.08%
We have mild expansions while MCHP is negative at -399.67%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-50.00%
We cut debt repayment yoy while MCHP is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
103.94%
We slightly raise equity while MCHP is negative at -11.27%. John Neff sees competitor possibly preserving share count or buying back shares.
No Data
No Data available this quarter, please select a different quarter.